ArticleJID innovations : skin science from molecules to population health2023

Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex.

Maxim A X Tollenaere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.